These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7209869)

  • 61. Changes in [3H]inositol-labelled phosphoinositides of pig platelets in response to thrombin.
    Lymberopoulos G; Hawthorne JN
    Biochim Biophys Acta; 1984 Nov; 805(3):285-90. PubMed ID: 6091780
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phenylbutazone inhibition of equine platelet function.
    Meyers KM; Lindner C; Katz J; Grant B
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thromboxane B2 production and lipid peroxidation in human blood platelets.
    Best LC; Jones PB; McGuire MB; Russell RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():297-9. PubMed ID: 7386271
    [No Abstract]   [Full Text] [Related]  

  • 64. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arachidonate transfer between platelets and lipoproteins.
    Surya II; Gorter G; Akkerman JW
    Thromb Haemost; 1992 Dec; 68(6):719-26. PubMed ID: 1287888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change.
    Lampugnani MG; de Gaetano G
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H440-5. PubMed ID: 6433724
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation.
    Mounier C; Faili A; Vargaftig BB; Bon C; Hatmi M
    Eur J Biochem; 1993 Aug; 216(1):169-75. PubMed ID: 8365403
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Response of human platelets exposed to arachidonate upon stimulation with other agonists: possible role of Ca2+i movement.
    Chen ZM; Cerletti C; de Gaetano G; Bertelé V
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1193-9. PubMed ID: 3122746
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders.
    Satoh K; Takamatsu S; Sakuta S; Mizuno S; Metoki H; Takamatsu M
    Jpn Circ J; 1981 Dec; 45(12):1335-41. PubMed ID: 7321143
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced malondialdehyde formation in reserpinized rabbit blood platelets.
    Watanabe Y; Soda M; Kobayashi B
    Thromb Res; 1979; 16(1-2):25-35. PubMed ID: 505420
    [No Abstract]   [Full Text] [Related]  

  • 71. The identification of trihydroxyeicosatrienoic acids as products from the incubation of arachidonic acid with washed blood platelets.
    Jones RL; Kerry PJ; Poyser NL; Walker IC; Wilson NH
    Prostaglandins; 1978 Oct; 16(4):583-9. PubMed ID: 725088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thrombin generation precedes platelet activation in native blood taken from the hand during multiple blood sampling following cold challenge.
    Tindall H; Menys VC; Davies JA
    Thromb Res; 1987 May; 46(4):613-6. PubMed ID: 3617016
    [No Abstract]   [Full Text] [Related]  

  • 73. Vitamin E consumption by human blood platelets activated by latex particles.
    Del Principe D; Menichelli A; Lubrano R; Bandino D; Di Giulio S; Di Corpo ML; Giardini O
    Am J Hematol; 1986 Apr; 21(4):351-6. PubMed ID: 3953557
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the inhibition of deoxynivalenol and T-2 toxin on bovine and porcine platelet function.
    Gentry PA; Bondy GS; Ross ML
    Mycotoxin Res; 1988 Mar; 4(1):25-32. PubMed ID: 23605106
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Historical perspective on ADP-induced platelet activation.
    Packham MA; Rand ML
    Purinergic Signal; 2011 Sep; 7(3):283-92. PubMed ID: 21484086
    [No Abstract]   [Full Text] [Related]  

  • 76. Protein expression in platelets from six species that differ in their open canalicular system.
    Choi W; Karim ZA; Whiteheart SW
    Platelets; 2010; 21(3):167-75. PubMed ID: 20196629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves.
    da Silva MB; Dessy C; Coghe J; David JL; Lekeux P
    Vet Res Commun; 1998 Jun; 22(4):273-91. PubMed ID: 9686442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues.
    Burke SE; Lefer AM; Nicolaou KC; Smith GM; Smith JB
    Br J Pharmacol; 1983 Feb; 78(2):287-92. PubMed ID: 6831115
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of platelet depletion on the unanesthetized sheep's pulmonary response to endotoxemia.
    Snapper JR; Hinson JM; Hutchison AA; Lefferts PL; Ogletree ML; Brigham KL
    J Clin Invest; 1984 Nov; 74(5):1782-91. PubMed ID: 6501570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.